Search Results - Thomas, Alissa

Refine Results
  1. 1
    Essential competencies in palliative medicine for neuro-oncologists

    Essential competencies in palliative medicine for neuro-oncologists by Thomas, Alissa A., Carver, Alan

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Immunotherapy for the Treatment of Glioblastoma

    Immunotherapy for the Treatment of Glioblastoma by Thomas, Alissa A., Ernstoff, Marc S., Fadul, Camilo E.

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    QLIF-15. PERI-OPERATIVE RISK FACTORS FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH MALIGNANT GLIOMA

    QLIF-15. PERI-OPERATIVE RISK FACTORS FOR VENOUS THROMBOEMBOLISM DEVELOPMENT IN PATIENTS WITH MALIGNANT GLIOMA by Wright, Heather, Douce, Daniel, Holmes, Chris, Thomas, Alissa

    Published 2017
    Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Vaccine-based immunotherapy for glioblastoma

    Vaccine-based immunotherapy for glioblastoma by Thomas, Alissa A, Fisher, Jan L, Ernstoff, Marc S, Fadul, Camilo E

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    RARE-30. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH LEPTOMENINGEAL DISSEMINATION RESPONSIVE TO BRAF INHIBITION AND BEVACIZUMAB

    RARE-30. ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA WITH LEPTOMENINGEAL DISSEMINATION RESPONSIVE TO BRAF INHIBITION AND BEVACIZUMAB by Thomas, Alissa, Tucker, Suzanne, Nelson, Carl, Nickerson, Joshua, Durham, Susan, Homans, Alan

    Published 2017
    Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    EPID-07. ACCESS TO GLIOBLASTOMA CLINICAL TRIALS FOR RURAL PATIENTS IN THE UNITED STATES FROM 2010–2020

    EPID-07. ACCESS TO GLIOBLASTOMA CLINICAL TRIALS FOR RURAL PATIENTS IN THE UNITED STATES FROM 2010–2020 by Nevel, Kathryn, Capouch, Samuel, Arnold, Lisa, Peters, Katherine, Mohile, Nimish, Thomas, Alissa

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules

    Cutaneous adverse drug reaction associated with oral temozolomide presenting as dermal and subcutaneous plaques and nodules by Virmani, Pooja, Chung, Esther, Thomas, Alissa A., Mellinghoff, Ingo K., Marchetti, Michael A.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Patient With Refractory Illness After 25 Months of Intensive Immunotherapy

    Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Patient With Refractory Illness After 25 Months of Intensive Immunotherapy by Thomas, Alissa, Rauschkolb, Paula, Gresa-Arribas, Núria, Schned, Alan, Dalmau, Josep O., Fadul, Camilo E.

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    NI-74 DYNAMIC CONTRAST ENHANCED (DCE) T1 MRI PERFUSION DIFFERENTIATES PSEUDOPROGRESSION FROM RECURRENT GLIOBLASTOMA

    NI-74 DYNAMIC CONTRAST ENHANCED (DCE) T1 MRI PERFUSION DIFFERENTIATES PSEUDOPROGRESSION FROM RECURRENT GLIOBLASTOMA by Thomas, Alissa, Perez, Julio Arevalo, Peck, Kyung, Schneider, Taylor, Lyo, John, Young, Robert, Kaley, Thomas

    Published 2014
    Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab

    Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab by Thomas, Alissa, Rosenblum, Marc, Karimi, Sasan, DeAngelis, Lisa M, Omuro, Antonio, Kaley, Thomas J

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    INNV-10. SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

    INNV-10. SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA by Thomas, Alissa, Wright, Heather, Walker, Hannah, Prasad, Prachi, Chan, Kelly, Tipirneni, Eswar, Goodwin, Andrew, Holmes, Chris

    Published 2019
    Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Multifocal metastases to choroid plexus from papillary thyroid carcinoma: illustrative case

    Multifocal metastases to choroid plexus from papillary thyroid carcinoma: illustrative case by Beach, Isidora R., Olszewski, Adam M., Thomas, Alissa A., DeWitt, John C., Liebelt, Brandon D.

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Intradural cauda equina Candida abscess presenting with hydrocephalus: case report

    Intradural cauda equina Candida abscess presenting with hydrocephalus: case report by Argersinger, Davis P., Natkha, Vitaliy P., Shepard, Matthew J., Thomas, Alissa A., Oler, Andrew J., Williamson, Peter R., Chittiboina, Prashant, Heiss, John D.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS)

    CLRM-13 RELEVANCE OF RECURSIVE PARTITIONING ANALYSIS (RPA) CLASSIFICATION IN THE CURRENT CARE OF PATIENTS WITH BRAIN METASTASES (BMETS) by Sarai, Guneet, Amidon, Ryan F, Bovi, Joesph A, Thomas, Alissa A, Novicoff, Wendy, Schuetz, Samantha, Singh, Rohit, Chang, Amy, Sheehan, Jason P, Fadul, Camilo E

    Published 2022
    Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients

    Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients by Zhang, Myron, Gulotta, Bryanna, Thomas, Alissa, Kaley, Thomas, Karimi, Sasan, Gavrilovic, Igor, Woo, Kaitlin M., Zhang, Zhigang, Arevalo-Perez, Julio, Holodny, Andrei I., Rosenblum, Marc, Young, Robert J.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect

    Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect by Ades, Steven, Herrera, Diego Adrianzen, Lahey, Tim, Thomas, Alissa A., Jasra, Sakshi, Barry, Maura, Sprague, Julian, Dittus, Kim, Plante, Timothy B., Kelly, Jamie, Kaufman, Peter A., Khan, Farrah, Hammond, Cory J., Gernander, Kelly, Parsons, Polly, Holmes, Chris

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology

    SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology by Chukwueke, Ugonma N, Vera, Elizabeth, Acquaye, Alvina, Hervey-Jumper, Shawn L, Odia, Yazmin, Klesse, Laura J, Dunbar, Erin, Sharma, Akanksha, Fonkem, Ekokobe, Thomas, Alissa A, Werbowetski-Ogilvie, Tamra E, Camelo-Piragua, Sandra, Gatson, Na Tosha N, de la Fuente, Macarena I, Armstrong, Terri S, Porter, Alyx B, Jackson, Sadhana

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Regulatory T cells are not a strong predictor of survival for patients with glioblastoma

    Regulatory T cells are not a strong predictor of survival for patients with glioblastoma by Thomas, Alissa A., Fisher, Jan L., Rahme, Gilbert J., Hampton, Thomas H., Baron, Udo, Olek, Sven, Schwachula, Tim, Rhodes, C. Harker, Gui, Jiang, Tafe, Laura J., Tsongalis, Gregory J., Lefferts, Joel A., Wishart, Heather, Kleen, Jonathan, Miller, Michael, Whipple, Chery A., de Abreu, Francine B., Ernstoff, Marc S., Fadul, Camilo E.

    Published 2015
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma

    Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma by Grommes, Christian, Tang, Sarah S., Wolfe, Julia, Kaley, Thomas J., Daras, Mariza, Pentsova, Elena I., Piotrowski, Anna F., Stone, Jacqueline, Lin, Andrew, Nolan, Craig P., Manne, Malbora, Codega, Paolo, Campos, Carl, Viale, Agnes, Thomas, Alissa A., Berger, Michael F., Hatzoglou, Vaios, Reiner, Anne S., Panageas, Katherine S., DeAngelis, Lisa M., Mellinghoff, Ingo K.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT

    COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT by Mrugala, Maciej, Ostrom, Quinn, Pressley, Shelley, Thomas, Alissa, Wefel, Jeffrey S, Coven, Scott, Acquaye, Alvina, Haynes, Chas, Agnihotri, Sameer, Lim, Michael, Peters, Katherine, Butowski, Nicholas, Hervey-Jumper, Shawn, Porter, Alyx, Oliver, Kathy, Dunbar, Erin, Taylor, Jennie, Schiff, David, Nassiri, Farshad, Hegi, Monika, Armstrong, Terri, van den Bent, Martin, Chang, Susan, Zadeh, Gelareh, Chheda, Milan

    Published 2020
    Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: